oxonic acid has been researched along with Feeding and Eating Disorders in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Feeding and Eating Disorders: A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unresectable advanced hepatocellular carcinoma is a heterogeneous disease, for which sorafenib is the first targeted agent approved for first-line therapy, and treatment options for patients with sorafenib-refractory advanced hepatocellular carcinoma are limited." | 2.84 | S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. ( Date, Y; Fang, X; Furuse, J; Hidaka, H; Ikeda, M; Kaneko, S; Kawazoe, S; Kudo, M; Moriguchi, M; Numata, K; Ohkawa, S; Okusaka, T; Sato, Y; Takeuchi, M; Tanaka, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, M | 1 |
| Moriguchi, M | 1 |
| Numata, K | 1 |
| Hidaka, H | 1 |
| Tanaka, H | 1 |
| Ikeda, M | 1 |
| Kawazoe, S | 1 |
| Ohkawa, S | 1 |
| Sato, Y | 1 |
| Kaneko, S | 1 |
| Furuse, J | 1 |
| Takeuchi, M | 3 |
| Fang, X | 1 |
| Date, Y | 1 |
| Okusaka, T | 1 |
| Hironaka, S | 1 |
| Sugimoto, N | 1 |
| Yamaguchi, K | 1 |
| Moriwaki, T | 1 |
| Komatsu, Y | 1 |
| Nishina, T | 1 |
| Tsuji, A | 1 |
| Nakajima, TE | 1 |
| Gotoh, M | 1 |
| Machida, N | 1 |
| Bando, H | 1 |
| Esaki, T | 1 |
| Emi, Y | 1 |
| Sekikawa, T | 1 |
| Matsumoto, S | 1 |
| Boku, N | 1 |
| Baba, H | 1 |
| Hyodo, I | 1 |
2 trials available for oxonic acid and Feeding and Eating Disorders
| Article | Year |
|---|---|
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Diarrhea; Double-Blind Method; Dru | 2017 |
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.
Topics: Adenocarcinoma; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Fre | 2016 |